FINWIRES · TerminalLIVE
FINWIRES

Dyno Nobel Earnings Favorably Exposed to Mining End Markets, Jefferies Says

By

-- Dyno Nobel's (ASX:DNL) earnings are favorably exposed to mining end markets and its integrated capacity amid a tight global market positions it favorably from impacts of the Middle East conflict, Jefferies said in a Tuesday note.

Jefferies forecast a first-half explosives earnings before interest and taxes (EBIT) of AU$190 million, around 2% over the consensus forecasts, and at the top end of Dyno Nobel's AU$460 million to AU$500 million fiscal year 2026 EBIT guidance range. It also forecast AU$123 million net profit after tax for the first half, which is around 2% above consensus on a continuing basis.

It lowered both its EBIT and earnings per share forecasts by around 1% in fiscal year 2026 to fiscal year 2028.

The investment firm retained its buy rating on Dyno Nobel with a price target of AU$3.90 per share.

Related Articles

Asia

Brightstar Resources Reports Higher March Quarter Group Mining Production

Brightstar Resources (ASX:BTR) said its group mining production for the March quarter came in at 58,700 tonnes at 3.3 grams per tonne (g/t) grade of gold for 6,250 ounces from its Laverton underground mining operations in Western Australia, according to a Wednesday Australian bourse filing.The company's group mining production for the March 2025 quarter came in at 28,200 tonnes at 3.3 g/t grade of gold for 3,002 ounces from its Laverton underground mining operations in Western Australia, per the filing.During the quarter, the Fish underground mine was transitioned to care and maintenance, with mining operations ceasing and the mine positioned to be ready for the recommencement of ore production in early 2027.The mining development and closure proposal for Lady Shenton open pit mine in Menzies was approved, the filing said.Brightstar Resources' shares fell nearly 1% in recent trading on Wednesday.

$ASX:BTR
Asia

Racura Oncology, University of Wollongong Win New South Wales Government Funding for Cancer Study

Racura Oncology (ASX:RAC) and the University of Wollongong secured funding under the New South Wales government's TechVouchers program to study the efficacy of (E,E)-bisantrene for certain types of breast and ovarian cancers, according to a Wednesday filing with the Australian bourse.A collaboration between Racura and the University aims to produce preclinical evidence for the development of RC220 as a new targeted therapy, per the filing.Results from the collaboration are expected to come out over the next 12 months.Racura Oncology shares gained 2% in recent Wednesday trade.

$ASX:RAC
Asia

JAC Motors Widens Q1 Loss, Revenue Up 17%

Anhui Jianghuai Automobile (SHA:600418), or JAC Motors, posted first-quarter attributable net loss of 606.0 million yuan, compared with 223.0 million yuan the previous year.Loss per share widened to 0.27 yuan from 0.10 yuan, according to a Wednesday filing with the Shanghai bourse.The automobile company's operating revenue went up 17% year over year to 11.5 billion yuan from 9.80 billion yuan.

$SHA:600418